These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1104 related articles for article (PubMed ID: 26800098)

  • 21. Effects of acteoside on lipopolysaccharide-induced inflammation in acute lung injury via regulation of NF-κB pathway in vivo and in vitro.
    Jing W; Chunhua M; Shumin W
    Toxicol Appl Pharmacol; 2015 Jun; 285(2):128-35. PubMed ID: 25902336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ethanol extracts of Rhaponticum uniflorum (L.) DC inflorescence ameliorate LPS-mediated acute lung injury by alleviating inflammatory responses via the Nrf2/HO-1 signaling pathway.
    Zhen D; Liu C; Huang T; Fu D; Bai X; Ma Q; Jiang M; Gong G
    J Ethnopharmacol; 2022 Oct; 296():115497. PubMed ID: 35738472
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Usnic acid protects LPS-induced acute lung injury in mice through attenuating inflammatory responses and oxidative stress.
    Su ZQ; Mo ZZ; Liao JB; Feng XX; Liang YZ; Zhang X; Liu YH; Chen XY; Chen ZW; Su ZR; Lai XP
    Int Immunopharmacol; 2014 Oct; 22(2):371-8. PubMed ID: 25068825
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Asiaticoside attenuates lipopolysaccharide-induced acute lung injury via down-regulation of NF-κB signaling pathway.
    Qiu J; Yu L; Zhang X; Wu Q; Wang D; Wang X; Xia C; Feng H
    Int Immunopharmacol; 2015 May; 26(1):181-7. PubMed ID: 25835778
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Naringin attenuates acute lung injury in LPS-treated mice by inhibiting NF-κB pathway.
    Liu Y; Wu H; Nie YC; Chen JL; Su WW; Li PB
    Int Immunopharmacol; 2011 Oct; 11(10):1606-12. PubMed ID: 21640201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glycitin alleviates lipopolysaccharide-induced acute lung injury via inhibiting NF-κB and MAPKs pathway activation in mice.
    Chen Y; Guo S; Jiang K; Wang Y; Yang M; Guo M
    Int Immunopharmacol; 2019 Oct; 75():105749. PubMed ID: 31306981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pogostone suppresses proinflammatory mediator production and protects against endotoxic shock in mice.
    Li YC; Xian YF; Su ZR; Ip SP; Xie JH; Liao JB; Wu DW; Li CW; Chen JN; Lin ZX; Lai XP
    J Ethnopharmacol; 2014 Nov; 157():212-21. PubMed ID: 25256685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gastrodin protects against LPS-induced acute lung injury by activating Nrf2 signaling pathway.
    Zhang Z; Zhou J; Song D; Sun Y; Liao C; Jiang X
    Oncotarget; 2017 May; 8(19):32147-32156. PubMed ID: 28389632
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Zingerone attenuates lipopolysaccharide-induced acute lung injury in mice.
    Xie X; Sun S; Zhong W; Soromou LW; Zhou X; Wei M; Ren Y; Ding Y
    Int Immunopharmacol; 2014 Mar; 19(1):103-9. PubMed ID: 24412620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Daidzein attenuates lipopolysaccharide-induced acute lung injury via toll-like receptor 4/NF-kappaB pathway.
    Feng G; Sun B; Li TZ
    Int Immunopharmacol; 2015 Jun; 26(2):392-400. PubMed ID: 25887269
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chikusetsusaponin V attenuates lipopolysaccharide-induced acute lung injury in mice by modulation of the NF-κB and LXRα.
    Su K; Zhang G; Zhang X; Jiang W
    Int Immunopharmacol; 2019 May; 70():174-179. PubMed ID: 30807930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-inflammatory effect of Yam Glycoprotein on lipopolysaccharide-induced acute lung injury via the NLRP3 and NF-κB/TLR4 signaling pathway.
    Niu X; Zang L; Li W; Xiao X; Yu J; Yao Q; Zhao J; Ye Z; Hu Z; Li W
    Int Immunopharmacol; 2020 Apr; 81():106024. PubMed ID: 31784404
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic effect of methyl salicylate 2-O-β-d-lactoside on LPS-induced acute lung injury by inhibiting TAK1/NF-kappaB phosphorylation and NLRP3 expression.
    Yang S; Yu Z; Yuan T; Wang L; Wang X; Yang H; Sun L; Wang Y; Du G
    Int Immunopharmacol; 2016 Nov; 40():219-228. PubMed ID: 27620503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective Effects of
    Shi K; Xiao Y; Dong Y; Wang D; Xie Y; Tu J; Xu K; Zhou Z; Cao G; Liu Y
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth hormone releasing peptide-2, a ghrelin agonist, attenuates lipopolysaccharide-induced acute lung injury in rats.
    Li G; Li J; Zhou Q; Song X; Liang H; Huang L
    Tohoku J Exp Med; 2010 Sep; 222(1):7-13. PubMed ID: 20805679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of alliin on LPS-induced acute lung injury by activating PPARγ.
    Wang YL; Guo XY; He W; Chen RJ; Zhuang R
    Microb Pathog; 2017 Sep; 110():375-379. PubMed ID: 28711511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cavidine Ameliorates Lipopolysaccharide-Induced Acute Lung Injury via NF-κB Signaling Pathway in vivo and in vitro.
    Niu X; Liu F; Li W; Zhi W; Zhang H; Wang X; He Z
    Inflammation; 2017 Aug; 40(4):1111-1122. PubMed ID: 28365871
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dexmedetomidine attenuates lipopolysaccharide induced acute lung injury in rats by inhibition of caveolin-1 downstream signaling.
    Liu J; Huang X; Hu S; He H; Meng Z
    Biomed Pharmacother; 2019 Oct; 118():109314. PubMed ID: 31545263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of magnolol on the Toll-like receptor 4/nuclear factor κB signaling pathway in lipopolysaccharide-induced acute lung injury in mice.
    Yunhe F; Bo L; Xiaosheng F; Fengyang L; Dejie L; Zhicheng L; Depeng L; Yongguo C; Xichen Z; Naisheng Z; Zhengtao Y
    Eur J Pharmacol; 2012 Aug; 689(1-3):255-61. PubMed ID: 22683864
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective effects of protocatechuic acid on acute lung injury induced by lipopolysaccharide in mice via p38MAPK and NF-κB signal pathways.
    Zhang X; Li C; Li J; Xu Y; Guan S; Zhao M
    Int Immunopharmacol; 2015 May; 26(1):229-36. PubMed ID: 25841318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 56.